July 2020 - Npos_2018 - lists.testbiotech.de

neuer Brief an Lambrecht (only German)
by Christoph Then 29 Jul '20

29 Jul '20

Hier mein Vorschlag. Bitte Rückmeldungen bis Ende der Woche, dann würde ich ihn gerne abschicken und auch der SPD im Bundestag zur Kenntnis geben. Parallel würde ich dann einen Besuch in Berlin mit Tomate und Brokkoli vorbereiten (vielleicht nur 10 Personen, 5 Masken Borkkoli, 5 Masken Tomate, professionell gemacht und mit Munch's 'der Schrei' klappt es dann mit der Positionierung, machen wir Smileys drüber (das wäre dann die doppelte Maskierungspflicht... ) kennt jemand gute MaskenbildnerInnen?

3 3

only German: Finale Version Brief an Lambrecht
by Christoph Then 28 Jul '20

28 Jul '20

Liebe Alle, vielen Dank an Martha, Annemarie und Johanna für Anmerkungen. hier die finale Version, ich schicke sie übermorgen ab, wenn es keine weiteren Kommentare gibt. herzlichen Gruß Christoph

1 0

Wie weiter mit Brief an Lambrecht? (only German)
by Christoph Then 25 Jul '20

25 Jul '20

Vielen Dank für positives Feedback! Es gibt u.a, vom BN auch Bereitschaft, den Brief zu zeichnen. Mein Vorschlag wäre hier es schlicht zu halten und einen Brief von Keine Patente auf Saatgut daraus zu machen. Ich unterschreibe und fertig. Ansonsten wäre die Möglichkeit, dass die Personen unrterschreiben, die in Berlin mit dabei waren. es müßten sonst eigentlich all 40 Organisationen zeichnen - das erscheint mir ein bißchen sehr großer Aufwand. Oder?

3 2

Members accepted
by Johanna Eckhardt no-patents-seeds.org 22 Jul '20

22 Jul '20

Dear all, following the vote from our members, ARCHE NOAH, SWISSAID, ProSpecieRara and the Danish Seed Savers have been accepted as members. The vote was unanimous (11 yes, 2 abstentions). The board will still sign the membership forms and send it to the organisations. Judith Reusser is not a member as a natural person anymore, but will continue to represent SWISSAID. Please find attached the list of members. Best, Johanna Johanna ECKHARDT Project Coordination Tel. +43 680 21 26 343 <mailto:johanna.eckhardt@no-patents-on-seeds.org> johanna.eckhardt(a)no-patents-on-seeds.org NO PATENTS ON SEEDS! <http://www.no-patents-on-seeds.org/> www.no-patents-on-seeds.org <http://www.facebook.com/nopatentsonseeds> www.facebook.com/nopatentsonseeds <http://www.twitter.com/nopatentsonseed> www.twitter.com/nopatentsonseed

1 0

wie weiter mit Politik? (German only)
by Christoph Then 20 Jul '20

20 Jul '20

Liebe Alle ich werden demnächst einen Brief an Lambrecht entwerfen, um die Sache dringlich zu machen. was haltet ihr davon, wenn wir das BMJV nach der Sommerpause mit ein paar großen Gemüseköpfen (etwa Dutzend Menschen mit Tomatenkopf etc) besuchen um das Thema für die Presse sichtbar zu machen? wir könnten was Nettes übergeben und die Presse für ein Foto einladen. Es könnte z.B. das bekannte Bild 'Der Schrei' auf Brokkoli und Tomate übetragen werden. Ich würde versuchen, professionelle Aktionskünstler zu bekommen. ich denke, wir müssen deutlich mehr Wind machen, sonst sitzen die uns aus. Nachdem das Telefonat mit dem EPA kurz gesagt, ergeben hat, dass wir die richtigen Forderungen haben, aber zu wenig Unterstützung im Verwaltungsrat spürbar ist, sollten wir das schleunigst ändern. herzlichen Gruß Christoph

3 2

short summary of the meeting with EPO
by Christoph Then 15 Jul '20

15 Jul '20

Dear all we just had a meeting with EPO as announced. it took around one hour. Johanna prepared some minutes which are however six pages - might take some time to check it (thanks a lot to Johanna, this was really very very fast!) So in short my quick take away. Please do not spread, we agreed not to run to detailed public communication, but to apply 'something like' chatam house rules (not so cleary defined)): * on essentially biological processes, they confirmed that they grant patents on plants derived from physico-chemical mutagenes. This would be in line what they grant on bacteria (which are not relevant for Article 53(b)). They agreed that there is room for interpretation whether this practice is in line with G2/07 and G1/08. They see some possibility for the Administrative Council to deal with this issue again and take decision. However they do not see a lot of interest among its members (lot of work for us). They think that most agree on current practice. * on cells: They try to find out if there is unclarity and how to deal with it. We agreed there might be a difference between living cells and products like sugar extracted from the plants. The EPO grants patent on cells cultured in-vitro (which can be used to create whole plants). They are currently assessing this practice. * on scope: They agreed that disclaimers are just an intermediary solution ('it allows the EPO to go on'). They could not tell us whether (in theory) in might be possible to exclude patents on products under Article 53 (b). But they might be interested to check. * on legal biding effect of G3/19 on pending applications: They can not change the decision of G3/19.. They mentioned it would be possible to run patent oppositions in national courts. * on participation in AC meeting: they see our point, there might be further discussions. There seems to be interest for further meetings for exchange of opinion between EPO and Npos after summer break. So my conclusions: We have a good strategy, our points are valid. We will need more support from the governments. We might choose Austria to take the lead. We should double our efforts in Germany and Netherlands. We should discuss whether the Swiss groups can give us more support by aligning with our strategy. We also should take a closer look on Belgium, Portugal and Denmark. next activity: another letter to German government, travel to Austria. Read the minutes from Johanna. cheers Christoph

3 3

draft agenda for phone call with EPO
by Christoph Then 09 Jul '20

09 Jul '20

Dear all as agreed, I drafted some agenda for the phone call on 14 July. please see below. I would send this draft (after corrections etc) to EPO tomorrow morning please let me know your comments thanks! Christoph Dear.. During the meeting with the EPO we would like to focus on for topics and then potentially discuss other issues. These four topics are (as outlinied in our letter): * definition of essentially biological processes * patentability of cells * scope of patents * effect of G3/19 on pending patent applications To discuss the issue, we propose the following agenda: 1. Short introduction of participants 2. Short summary of problems remaining or newly emerging after G3/19 from the perspective of No Patents on Seeds! 3. Some comments from the EPO on the problem analysis of No Patents on Seeds! 4. First round of discussion / questions 5. Short summary of possible solutions as proposed by No Patents on Seeds! 6. Some comments from the EPO on the solutions analysis of No Patents on Seeds! 7. Second round of discussion / questions 8. Short summary on the findings 9. Other issues such as transparency and CSO participation in meetings of the Administrative Council 10. Further exchanges of views between No Patents on Seeds and the EPO in near future

3 3

FW: EPO newsletter 13/2020: EPO’s Annual Review 2019
by Johanna Eckhardt no-patents-seeds.org 09 Jul '20

09 Jul '20

Dear all, the EPO has published its annual report for 2019 <https://www.epo.org/news-events/news/2020/20200630a.html> (see newsletter below) giving an update on implementing their “Strategic Plan 2023”. Since we talked about it at our last conference call: there is no mention whatsoever about the Observatory. - In the Strategic Plan they outlined that they wanted to create an Observatory: Strategic Plan 2023 <https://www.epo.org/about-us/office/strategy.html> : “[...] the EPO will create an observatory serving as an inclusive platform that brings together public and private stakeholders from across civil society to discuss and debate developments in innovation and patents.” Best, Johanna Johanna ECKHARDT Project Coordination Tel. +43 680 21 26 343 <mailto:johanna.eckhardt@no-patents-on-seeds.org> johanna.eckhardt(a)no-patents-on-seeds.org NO PATENTS ON SEEDS! <http://www.no-patents-on-seeds.org/> www.no-patents-on-seeds.org <http://www.facebook.com/nopatentsonseeds> www.facebook.com/nopatentsonseeds <http://www.twitter.com/nopatentsonseed> www.twitter.com/nopatentsonseed From: European Patent Office [mailto:website@epo.org] Sent: Thursday, July 9, 2020 11:02 AM To: johanna.eckhardt(a)no-patents-on-seeds.org Subject: EPO newsletter 13/2020: EPO’s Annual Review 2019 ‌ ‌ ‌ ‌ ‌ <https://epo.newsweaver.co.uk/newsletter-epo-org/tracking/1wffn277864.00126p…> EPO newsletter 13/2020 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ Not displaying correctly? <https://epo.newsweaver.co.uk/newsletter-epo-org/czoefpd808o1wffn277864?emai…> Read in web browser <https://epo.newsweaver.co.uk/v2files/shard1/7741/f9/4df6ed40c669b7967f910b.…> 09.07.2020 <https://epo.newsweaver.co.uk/v2files/shard1/7741/e7/d04dcf042f8d7f148fcaf1.…> EPO newsletter 13/2020 Dear Johanna Eckhardt, In this issue of the newsletter we share our new Annual Review for 2019, details of the release of search statements to help scientists in the fight against coronavirus, and the latest issue of the Official Journal. <https://epo.newsweaver.co.uk/newsletter-epo-org/1kxp289iz3v1wffn277864/exte…> <https://epo.newsweaver.co.uk/newsletter-epo-org/1kxp289iz3v1wffn277864/exte…> EPO’s Annual Review 2019 published: progress made on strategic plan The EPO has published its new-format Annual Review 2019 highlighting the progress made in implementing its Strategic Plan 2023 (SP2023). Replacing the former annual report, the review outlines the EPO’s main achievements under each of the five SP2023 goals. It includes key operational results, as well as detailed reports on quality, environmental sustainability, risk management, social aspects, engagement, international co-operation, communication and IT. <https://epo.newsweaver.co.uk/newsletter-epo-org/1kxp289iz3v1wffn277864/exte…> Read more <https://epo.newsweaver.co.uk/newsletter-epo-org/ogg4erotzq11wffn277864/exte…> <https://epo.newsweaver.co.uk/newsletter-epo-org/ogg4erotzq11wffn277864/exte…> Fighting coronavirus The EPO is committed to sharing with the public the latest patent information and knowledge on technologies which are useful in combatting the virus. EPO patent examiners who are experts in the technologies involved in the fight against coronavirus infections have created a variety of search statements to help scientists identify the most relevant documents in these fields. <https://epo.newsweaver.co.uk/newsletter-epo-org/ogg4erotzq11wffn277864/exte…> Read more <https://epo.newsweaver.co.uk/newsletter-epo-org/8el4jxoz0bm1wffn277864/exte…> <https://epo.newsweaver.co.uk/newsletter-epo-org/8el4jxoz0bm1wffn277864/exte…> Oral proceedings in case G 1/19 before the Enlarged Board of Appeal The EPO's Enlarged Board of Appeal has scheduled public oral proceedings in case G 1/19 for 15 July 2020. Members of the media and the public will be able to livestream the proceedings over the internet. <https://epo.newsweaver.co.uk/newsletter-epo-org/8el4jxoz0bm1wffn277864/exte…> Read more <https://epo.newsweaver.co.uk/newsletter-epo-org/1sgrqovgdpy1wffn277864/exte…> <https://epo.newsweaver.co.uk/newsletter-epo-org/1sgrqovgdpy1wffn277864/exte…> Joint statement by the EPO and CNIPA on response to COVID-19 The EPO and the China National Intellectual Property Administration (CNIPA) stand in full solidarity with all those affected by COVID-19. In these difficult times, we are united in our efforts to support users based on the long-term, friendly and dynamic co-operation between our offices. <https://epo.newsweaver.co.uk/newsletter-epo-org/1sgrqovgdpy1wffn277864/exte…> Read more <https://epo.newsweaver.co.uk/newsletter-epo-org/1rsktt3ut5q1wffn277864/exte…> <https://epo.newsweaver.co.uk/newsletter-epo-org/1rsktt3ut5q1wffn277864/exte…> Information about access to oral proceedings by videoconference before opposition divisions Oral proceedings before opposition divisions are public, unless the division decides otherwise. Any person may request to remotely attend oral proceedings held by videoconference in opposition proceedings. <https://epo.newsweaver.co.uk/newsletter-epo-org/1rsktt3ut5q1wffn277864/exte…> Read more <https://epo.newsweaver.co.uk/newsletter-epo-org/lwpq621vern1wffn277864/exte…> <https://epo.newsweaver.co.uk/newsletter-epo-org/lwpq621vern1wffn277864/exte…> Boards of Appeal annual report 2019 now available The latest annual report of the Boards of Appeal provides in-depth information and statistics on the Boards, including developments in 2019. <https://epo.newsweaver.co.uk/newsletter-epo-org/lwpq621vern1wffn277864/exte…> Read the report <https://epo.newsweaver.co.uk/newsletter-epo-org/13y97i38mbe1wffn277864/exte…> <https://epo.newsweaver.co.uk/newsletter-epo-org/13y97i38mbe1wffn277864/exte…> Coronavirus (COVID-19) – continually updated information The EPO is closely monitoring the global spread of the novel coronavirus (COVID-19) and has a dedicated webpage with the latest precautionary measures for external partners and potential visitors to the EPO. <https://epo.newsweaver.co.uk/newsletter-epo-org/13y97i38mbe1wffn277864/exte…> Stay up to date Searching for patents <https://epo.newsweaver.co.uk/newsletter-epo-org/1x13of0hdcb1wffn277864/exte…> <https://epo.newsweaver.co.uk/newsletter-epo-org/1x13of0hdcb1wffn277864/exte…> Espacenet 1.12.0 release notes The latest release of Espacenet lets you see at a glance which applications have been granted. Also, the result list now contains the documents most closely matching the search criteria plus all other kind codes available. <https://epo.newsweaver.co.uk/newsletter-epo-org/1x13of0hdcb1wffn277864/exte…> Find out more Law & practice <https://epo.newsweaver.co.uk/newsletter-epo-org/iuyslu65hrz1wffn277864/exte…> <https://epo.newsweaver.co.uk/newsletter-epo-org/iuyslu65hrz1wffn277864/exte…> Official Journal June 2020 The latest issue includes a notice concerning new Rule 20.5bis PCT on the correction of erroneous filings in procedures before the EPO and other information relevant for practitioners. <https://epo.newsweaver.co.uk/newsletter-epo-org/iuyslu65hrz1wffn277864/exte…> Browse the OJ Learning & events <https://epo.newsweaver.co.uk/newsletter-epo-org/2cg7o8nf5jp1wffn277864/exte…> <https://epo.newsweaver.co.uk/newsletter-epo-org/2cg7o8nf5jp1wffn277864/exte…> 3D printing conference goes digital Join the EPO and the EUIPO from 13 to 16 July for "Shaping tomorrow: 3D printing and its impact on IP", a digital conference on the challenges and opportunities of 3D printing, including IP protection strategies and more. Attendance is free but registration is required. <https://epo.newsweaver.co.uk/newsletter-epo-org/2cg7o8nf5jp1wffn277864/exte…> Register now Learning & events <https://epo.newsweaver.co.uk/newsletter-epo-org/1ve3jhd7bz01wffn277864/exte…> <https://epo.newsweaver.co.uk/newsletter-epo-org/1ve3jhd7bz01wffn277864/exte…> Patent Litigation in Europe – at a glance Use our new clickable map for quick access to an overview of the national procedures for administrative patent prosecution and civil patent litigation and enforcement in each of the EPC contracting states. <https://epo.newsweaver.co.uk/newsletter-epo-org/1ve3jhd7bz01wffn277864/exte…> Find out more <https://epo.newsweaver.co.uk/newsletter-epo-org/14hbzgvo7441wffn277864/exte…> <https://epo.newsweaver.co.uk/newsletter-epo-org/14hbzgvo7441wffn277864/exte…> EQE pre-examination paper – online training course Don't miss this extensive online training course if you are preparing for the EQE pre‑examination 2021! Put your questions to experienced epi tutors in virtual classrooms. Access various resources such as videos, articles, quizzes and case studies. The course will start on 1 September 2020. <https://epo.newsweaver.co.uk/newsletter-epo-org/14hbzgvo7441wffn277864/exte…> Register now <https://epo.newsweaver.co.uk/newsletter-epo-org/kj4nqankwzj1wffn277864/exte…> <https://epo.newsweaver.co.uk/newsletter-epo-org/kj4nqankwzj1wffn277864/exte…> Webinars on IP management We have just released a set of webinar recordings around IP management. Aimed at IP managers in technology-driven SMEs, the webinars introduce essentials in strategic management of IP assets. The focus is on value-based strategies for IP creation, and IP value extraction as an integral part of innovation strategy. <https://epo.newsweaver.co.uk/newsletter-epo-org/kj4nqankwzj1wffn277864/exte…> Watch now Thank you and best regards, The EPO’s online communication team Did you know ... ? We provide an overview of all our publications on our website. <https://epo.newsweaver.co.uk/newsletter-epo-org/1r178lfmqzz1wffn277864/exte…> Browse EPO publications <https://epo.newsweaver.co.uk/newsletter-epo-org/1ofdk9fvcut1wffn277864/exte…> <https://epo.newsweaver.co.uk/nwstatic/spacer.gif> <https://epo.newsweaver.co.uk/newsletter-epo-org/1dqnxpl926y1wffn277864?emai…> <https://epo.newsweaver.co.uk/newsletter-epo-org/4drkb2428dk1wffn277864/exte…> epo.org <https://epo.newsweaver.co.uk/newsletter-epo-org/ovq1n30i0081wffn277864/exte…> <https://epo.newsweaver.co.uk/newsletter-epo-org/12fsyycuq351wffn277864/exte…> <https://epo.newsweaver.co.uk/newsletter-epo-org/15vui2a27iz1wffn277864/exte…> <https://epo.newsweaver.co.uk/newsletter-epo-org/c0trs39kd0z1wffn277864/exte…> Add <mailto:website@epo.org> website(a)epo.org to your contacts to ensure that our emails reach your inbox. European Patent Organisation, represented by the President of the European Patent Office, António Campinos > <https://epo.newsweaver.co.uk/newsletter-epo-org/c2r8w6ip3p41wffn277864/exte…> Legal notice > <https://epo.newsweaver.co.uk/newsletter-epo-org/1froggg47w01wffn277864/exte…> Privacy statement This email was sent to <mailto:johanna.eckhardt@no-patents-on-seeds.org> johanna.eckhardt(a)no-patents-on-seeds.org from website(a)epo.org <https://epo.newsweaver.co.uk/newsletter-epo-org/unsubscribe/unsubscribe.htm…> Unsubscribe | <https://epo.newsweaver.co.uk/newsletter-epo-org/czoefpd808o1wffn277864/abus…> Report Misuse | <https://epo.newsweaver.co.uk/newsletter-epo-org/subscriber/switchFormat.htm…> Receive in Plain Text

1 0

Fwd: Patente: Die Antwort der Ministerin (German version)
by Christoph Then 08 Jul '20

08 Jul '20

Liebe Alle die Antwort der Ministerin ist da. leider nicht sehr hilfreich. 1. zur Frage der Definition von im Wesentlichen biologischen Verfahren stimmt sie uns zu, dass die von uns zitierten Entscheidungen (G1/08 , G2/07) relevant sind. Sie sieht aber keinen Widerspruch zum Beschluss des Verwaltungsrates (beziehungsweise der Beschlussvorlage) im Juni 2017. das würde bedeuten: Auch Patente wie die von Carlsberg sind rechtmässig erteilt worden. Im direkten Gespräch hatte die Ministerin dazu eine andere Meinung. Diese Antwort ist für uns so nicht akzeptabel. 2. in Bezug zu Patenten auf Zellen stellt sie diese gleich mit Extrakten aus Pflanzen (wie Zuckermoleküle) die sich nicht vervielfältigen können. Das ist Quatsch. Isolierte Zellen von Pflanzen und Tieren können im Labor dazu genutzt werden, auch wieder ganze Pflanzen und Tiere zu regenerieren. Zwar sind (laut Beschluss des Verwaltungsrates) Samen, Spermien oder Eizellen von der Patentierbarkeit ausgenommen. also die Zellen, die man normalerweise zur Fortpflanzung nutzt. Wir haben kein Problem mit Zellextrakten - aber warum ist dann in der Beschlussvorlage vom Juni 2017 von Zellen die Rede? Es gibt hier offensichtlich eine Grauzone, über die man gar nicht sprechen will. 3. Die Reichweite von Patenten sei duch die Disclaimer-Regelung (also das Einfügen von Ausschlußkriterien in die claims) bereits gelöst. Hier sind wir nicht so sicher. Wir sehen Bedarf für gesetzliche Regelungen (Deutsches Patentgesetz) 4. Die Feststellung der Großen Beschwerdekammer, dass G3/19 nicht für Patente gilt, die vor Juli 2017 angemeldet wurden, sei nicht zu beanstanden. Hier erwarten wir deutlich mehr Engagement, um die grundlegenden Rechtsfragen zu klären. 5. Wir hatten verlangt, dass die Dokumente veröffentlicht werden, die der Entscheidung G3/19 zugrunde liegen veröffentlicht werden. Das scheint erfolgt zu sein. Wir hatten aber auch gefordert, dass die Zivilgesellschaft in gleichem Umfang in die Entscheidungen des Verwaltungsrates einbezogen werden, wie die Industrie. Davon kein Wort in der Antwort. Nun gut. leider mal wieder das Spiel mit freundlichen Worten ohne Inhalt. Wir sollten einen weiteren Brief schreiben mit einfachen Fragen: * wenn die Entscheidung G1/08 und G2/07 nicht in Widerspruch zur Entscheidung des Verwaltungsrates stehen, warum wurden dann Patente wie die von Carlsberg erteilt? * Ist die Ministerin der Aufassung, dass die Patente rechtmässig erteilt wurden? * welche nicht vermehrunsgfähigen Zellen sind patentierbar und wo ist das geregelt, dass es nur Zellextrakte sind? wir sollten unsere Kritik und Unzufriedenheit mit Antworten 3-6 ausdrücken. Nächste Woche (14.7.) haben wir ein Telefonat mit dem EPO über diese Fragen. Wir würden das gerne abwarten, bevor wir den Brief ggf. öffentlich machen oder einen neuen Brief schreiben. wir werden euch informieren - ich hoffe, das ist so ok. Nochmal vielen Dank für Eure Unterstützung! gemeinsam schaffen wir das. Christoph

1 0

letter from German ministry
by Christoph Then 08 Jul '20

08 Jul '20

dear all we received a letter from German Minister of Justice. Sorry to say, it does not to seem to be very helpful. 1. on essentially biological processes: they agree with us that G1/08 and G2/07 are relevant, but they also say, that the decision of June 2017 and the preparatory document of the President are in line with it. 2. They see no problems with patents on cells. If I understand them correctly, they consider these cells as products derived from plants and animals which are able to reproduce. This a funny interpretation. It is correct that semen and seeds (as being cells) can not be patented (as stated in the preparatory document of the President). However, also isolated cells, kept in laboratory, can be used to develop to whole plants or animals. So there is some grey zone, they do not want to discuss. 3. the scope of patents already would be perfectly organised by the disclaimer 4. it seems to be ok that the G3/19 decision has no effect on pending patents 5. they say, the documents as referred to in G3/19 were published (but no mentioning of participation in the AC-meetings). Summary: This seems the old political game of friendly answering without much content. We should come back to the Minister in another letter asking clear questions such as: * if the decision of the Admin Council is in line with G1/08, why further patents were granted on random mutations * is the Minister of the opinion that these patents were granted lawfully and should be granted in future (in our meeting she was of opposite opinion) * which cells do not reproduce (and where is the legal definition for it) further, we should express disagreement and show doubts with points 3-5. I also have to inform the other organisations about the answer. I will do this in German and then also send the German interpretation to this list. I suggest not to run public communication on the letter and to write no further letter before we had the phone call with the EPO next week. cheers Christoph

1 0